Related Experiment Video
Updated: Aug 2, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Mitochondrial calcium uniporter b deletion inhibits platelet function and reduces susceptibility to arterial
Madankumar Ghatge1, Manasa K Nayak1, Gagan D Flora1
1Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa, Iowa City, Iowa, USA.
Insights
Mitochondrial calcium uniporter b (MCUb) limits mitochondrial calcium uptake. Deleting MCUb in mice reduces platelet activation and thrombosis, revealing its role in platelet function and arterial thrombosis.
Area of Science:
- Cardiovascular Biology
- Mitochondrial Physiology
- Platelet Biology
Background:
- Mitochondrial calcium uniporter b (MCUb) is a known inhibitor of mitochondrial calcium uptake.
- The specific function of MCUb in regulating platelet activity and thrombosis is not well understood.
Purpose of the Study:
- To investigate the role of MCUb in platelet function and thrombosis using MCUb knockout (MCUb-/-) mice.
Main Methods:
- In vitro platelet activation assays.
- In vivo arterial thrombosis models (FeCl3 and laser injury).
- Measurement of glycolytic proton efflux and oxygen consumption rates.
Main Results:
- MCUb-/- platelets showed impaired activation, aggregation, and secretion.
- MCUb-/- mice exhibited reduced susceptibility to arterial thrombosis.
- Mitochondrial calcium uptake in MCUb-/- platelets correlated with altered glucose metabolism and reduced pyruvate dehydrogenase phosphorylation.
Conclusions:
- MCUb plays a critical role in platelet activation and arterial thrombosis.
- Mitochondrial calcium signaling is functionally linked to glucose metabolism in activated platelets.
Background:
Mitochondrial calcium uniporter b (MCUb) is a negative regulator of the mitochondrial calcium uniporter (MCU) and is known to limit mitochondrial calcium ion (Ca2+) uptake. The role of MCUb in platelet function remains unclear.
Objectives:
Utilizing MCUb-/- mice, we examined the role of MCUb in regulating platelet function and thrombosis.
Methods:
Platelet activation was evaluated in agonist-induced standardized in vitro assays. Susceptibility to arterial thrombosis was evaluated in FeCl3 injury-induced carotid artery and laser injury-induced mesenteric artery thrombosis models. The glycolytic proton efflux rate and oxygen consumption rate were measured to evaluate aerobic glycolysis.
Results:
Upon stimulation, MCUb-/- platelets exhibited reduced cytoplasmic Ca2+ responses concomitant with increased mitochondrial Ca2+ uptake. MCUb-/- platelets displayed reduced agonist-induced platelet aggregation and spreading on fibrinogen and decreased α and dense-granule secretion and clot retraction. MCUb-/- mice were less susceptible to arterial thrombosis in FeCl3 injury-induced carotid and laser injury-induced mesenteric thrombosis models with unaltered tail bleeding time. In adoptive transfer experiments, thrombocytopenic hIL-4Rα/GPIbα-transgenic mice transfused with MCUb-/- platelets were less susceptible to FeCl3 injury-induced carotid thrombosis compared with hIL-4Rα/GPIbα-Tg mice transfused with wild type platelets, suggesting a platelet-specific role of MCUb in thrombosis. MCUb-/- stimulated platelets exhibited reduced glucose uptake, decreased glycolytic rate, and lowered pyruvate dehydrogenase phosphorylation, suggesting that mitochondrial Ca2+ mediates bioenergetic changes in platelets.
Conclusion:
Our findings suggest that mitochondrial Ca2+ signaling and glucose oxidation are functionally linked in activated platelets and reveal a novel role of MCUb in platelet activation and arterial thrombosis.
Related Concept Videos
ATP Synthase: Mechanism
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
ATP Synthase: Structure

